Navigation Links
Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C

on PROVE 2 data, regimens that may exclude RBV. Vertex expects to focus on treatment durations of no more than 24 weeks. Vertex and Tibotec are planning to meet with regulatory authorities to discuss the Phase 3 design in mid-2007 and are planning to initiate Phase 3 clinical development in the fourth quarter of 2007. The registration strategy and timing of an NDA filing will be dependent on discussions with regulatory authorities.

PROVE 1 Results at EASL

Interim 12-week antiviral analysis of PROVE 1

A total of 250 patients were enrolled in PROVE 1 and received at least one dose of telaprevir or placebo in addition to Peg-interferon alfa-2a (peg-IFN) + ribavirin (RBV) in the study. A total of 175 patients received at least one dose of telaprevir in 1 of 3 arms (treatment arms B, C and D) and 75 patients received at least one dose of placebo (arm A). Treatment with telaprevir resulted in a high proportion of patients achieving a rapid viral response at 4 weeks. At the time of the interim analysis, all patients had either completed 12 weeks or discontinued from the study prior to week 12. Available 4-week and 12-week results are detailed in the following table: -0-

 Interim HCV RNA results for Patients Enrolled in the PROVE 1 Trial

---------------------------------------------------------------------

Treatment Assignment            Patients Patients Patients Patients

                                 with     with     with     with HCV

                                 HCV RNA  HCV RNA  HCV RNA  RNA (less

                                 (less    (less    (less    than)10

                                 than)30  than)10  than)10  IU/mL at

                                 IU/mL    IU/mL    IU/mL    end of 12

                                 at end   at end   at end   weeks of

                                 of 4     of 4     of 12    dosing

                                 weeks    weeks    weeks    (last on-

                 
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Post Your Comments:
(Date:8/27/2014)... By now, if you haven,t heard about the ... planet. The awareness campaign has brought this devastating disease to ... over $88.5 Million (and counting) for ALS. Every day, more ... starting to as well. One such company, Acorn ... who actually works with ALS sufferers and helps to provide ...
(Date:8/27/2014)... CHICAGO , Aug. 27, 2014  Hill-Rom Holdings, ... listen to a management presentation at the Morgan Stanley ... p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ... be available one hour after conclusion of the live ...
(Date:8/27/2014)... 27, 2014 North American lighting leader OSRAM ... Award for the new OSRAM ITOS ® PHASER ® ... module for microscopy, endoscopy and surgical head lamps that delivers ... efficacy and lamp life. "We,re honored to be ... most innovative new technologies of the past year," said ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... 2014 According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:8/27/2014)... The National League for Nursing is pleased ... FAAN, became the inaugural director of the NLN/Chamberlain ... Science of Nursing Education , effective August 11. The ... Home for Transformative Excellence, established with the League’s historic ... , Under Dr. Dennis’s leadership, the NLN/Chamberlain Center will ...
(Date:8/27/2014)... Delta, a reliable supplier of high ... Cat D7R Dozers to its used bulldozer ... announced that all these items are offered with deep ... expand Delta’s market share in the coming September. ... special offer; he has much confidence in the discounted ...
(Date:8/27/2014)... FL (PRWEB) August 27, 2014 Millennium ... now a sponsor for Florida Mental Health Counselors Association ... benefits the new sponsorship is sure to provide. , ... professional needs of Florida’s licensed mental health counselors. The ... the American Counseling Association (ACA) and since then, it ...
(Date:8/27/2014)... NY (PRWEB) August 27, 2014 The ... Team ) is holding free events about “ Sexuality ... speaker Liz Treston. These straightforward and entertaining discussions are ... at Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and ... Central Avenue, Bethpage, NY). , The New York ...
Breaking Medicine News(10 mins):Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
... Not Meeting Daily Physical,Activity Recommendations, INDIANAPOLIS, May ... homes are unlikely to be meeting physical activity,recommendations ... today,at the 55th Annual Meeting of the American ... family child care homes, as the second,largest child ...
... to Fitness, INDIANAPOLIS, May 30 If walking seems ... a stroll is,an easy way to lower pressure and for ... presented findings today at the,55th Annual Meeting of the American ... obese patients was designed to determine if,brisk walking alone was ...
... To Be Completed Within Automatic Form 10-K Extension ... ... May 30 KV Pharmaceutical Company,(NYSE: KVa/KVb), a fully integrated specialty ... prescription pharmaceuticals,announced today that it expects to complete and file its ...
... deployed in regions of the world where tuberculosis (TB) ... military now faces a growing medical problem. But it ... the problem lies with the growing number of pseudoepidemics, ... result of universal testing with a notoriously inaccurate tuberculin ...
... 30 The new University of,Detroit Mercy School of ... Saturday, May 31 from 9 a.m. to 1 p.m. ... offering free dental screenings for community,members, as well as ... held in celebration of the School of Dentistry,s 75th,Anniversary., ...
... MD, RDMS, of Christiana Care Health System, Wilmington, DE, ... with immediate access to patient medical records during a ... radiofrequency devices that electronically contain a persons medical records ... reduce medical charges, two often incompatible goals. , ...
Cached Medicine News:Health News:Preschoolers in Family Child Care Homes Need More Activity 2Health News:Brisk Walking Lowers Blood Pressure, Increases Fitness in Obese 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 3Health News:US soldiers in high-tuberculosis areas face new epidemic: false positives 2Health News:UDM School of Dentistry to Host Community Open House 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: